🧪 Materials Science🖨️ 3D Printing🧬 Smart Matter🛰️ R&D Simulators
🔴 All Mars NewsRocketry & VehiclesColonization & HabitatsSurface ResearchScience & DiscoveryMissions & Agencies
← All Mars news

3D Bioprinted Organ Models Market Valued at $1.9 Billion

🇫🇷 GN impression 3D (FR)3D PrintingMon, 15 Jul 2019 07:00:00 GMT· translated & edited
3D Bioprinted Organ Models Market Valued at $1.9 Billion

The market for 3D bioprinted organ models is projected to reach $1.9 billion, indicating significant growth potential in the field of regenerative medicine and drug development.

The global market for 3D bioprinted organ models is anticipated to reach a substantial valuation of $1.9 billion. This projection highlights a rapidly expanding sector within additive manufacturing, specifically focused on biological applications.

These bioprinted models serve a crucial role in various stages of research and development. They are utilized for drug discovery and testing, offering a more physiologically relevant alternative to traditional cell cultures or animal models. This can lead to more accurate predictions of drug efficacy and toxicity, potentially reducing the cost and time associated with pharmaceutical development.

Furthermore, 3D bioprinted organ models are instrumental in advancing regenerative medicine. Researchers are exploring their use for studying disease mechanisms and for developing personalized treatment strategies. The ability to create complex, tissue-specific structures allows for a deeper understanding of cellular interactions and tissue development.

The increasing demand for advanced preclinical testing solutions and the ongoing advancements in bioprinting technology are key drivers for this market's growth. As the technology matures, the fidelity and complexity of these bioprinted organ models are expected to improve, further expanding their applications and market value.

Editor's Analysis — through the multi-planetary lens

The $1.9 billion valuation of the 3D bioprinted organ models market underscores the significant translation of additive manufacturing into the life sciences. These models are crucial for accelerating drug development and understanding disease, offering a path towards more personalized medicine and reducing reliance on animal testing. This development aligns with the broader AM trend of creating complex, functional structures for specialized applications, extending beyond industrial parts to biological systems.

Original headline: Modèles d’organes bio-imprimés 3D, un marché qui vaut $1,9 milliard - 3d adept media
Read the full story at GN impression 3D (FR) →

Edited by the news editor with AI and translated into English from the original report — please refer to the original source.

More Mars news